Onesource Specialty Pharma Limited has informed the Exchange regarding the receipt of in-principle approval from the Government of Karnataka for the application submittedby the Company for its Unit II expansion project under the Karnataka Industrial Policy (KIP) 2025 30, towards incentives and concessions.'.
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
OneSource Specialty Pharma Limited has received in-principle approval from the Government of Karnataka for its Unit II expansion project at Doddaballapur Taluk, Bengaluru Rural District. The approval was granted under the Karnataka Industrial Policy (KIP) 2025-30 and provides incentives and concessions. The expansion was approved in the 67th State High Level Clearance Committee meeting held on April 13, 2026, with the Government Order received on May 15, 2026. Unit II is described as a flagship facility, and the expansion aims to enhance manufacturing capacities to service global partners. No specific investment amount or timeline has been disclosed in this filing.
This approval signals the company's intent to scale up its manufacturing capabilities, which could support future revenue growth from global partners. However, the actual impact on financials and timelines remains contingent on project execution, and no immediate stock movement is expected from this regulatory update alone.